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chenjg118@sohu.cAbstract The aim of this study was to investigate whether the gross saponins of Tribulus terrestris
(GSTT), a traditional Chinese herbal medicine, have neuroprotective effects on rats subjected to
middle cerebral artery occlusion (MCAO), through nuclear factor-kB (NF-kB) pathway and
inﬂammatory mediators. Cerebral ischemia was produced by MCAO in either untreated (control)
or GSTT-pretreated rats, and the animals were examined for infarct volume, cerebral edema,
neuro-behavioral abnormality and pathological changes. Meanwhile, the expression of NF-kB
protein in brain tissue was analyzed on Western blots and the serum levels of TNF-a and IL-1 were
determined by ELISA. The experimental results demonstrated that, compared with the control
MCAO group, GSTT-pretreated MCAO group had signiﬁcantly reduced infarct volume, brain
edema and neuro-behavioral abnormality, and lesser degree of pathologic changes in the brain, as
well as had lower levels of serum TNF-a and IL-1b, and higher levels of brain NF-kB (Po0.05).
Furthermore, treatment with an NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC) abolished
the protective effects of GSTT against MCAO-induced cerebral ischemic injury. These resultsedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association. Production and
rved.
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En-ping Jiang et al.22indicated that GSTT’s ability to protect against cerebral ischemic injury was mediated through the
NF-kB signaling pathway, and that GSTT may act through inhibition of the production of
inﬂammatory mediators.
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Cerebral ischemia is one of the common diseases that have the
most devastating effects on human beings1. During cerebral
ischemia, inﬂammation is closely interrelated with neuronal cell
death and thereby promotes the neurological deﬁcit. Inﬂam-
mation and apoptosis both depend largely on alterations in
gene expression and share key regulators, transcription factor
nuclear factor-kB (NF-kB) being a prominent example. NF-kB
includes at least ﬁve DNA-binding protein subunits. The
classic form of NF-kB consists of two subunits, p50 and p65,
which form homo- and heterodimers2. NF-kB, which is well
known for its antiapoptotic function3,4, plays an important role
in the protection against cerebral ischemia injury. The protec-
tive effect of ischemic preconditioning has been shown to be
mediated by NF-kB5. NF-kB can protect neurons from the
ischemic injury induced by middle cerebral artery occlusion
(MCAO)6. Cytokines, such as tumor necrosis factor a (TNF-a)
and IL-1b, can activate NF-kB in response to ischemia. Some
evidence indicates that TNF cytotoxicity can be dependent on
the loss of NF-kB activity7 and that under-expression of
activated NF-kB in the ischemic cerebral cortex can inﬂuence
neuronal sensitivity to TNF-induced apoptosis8.
The use of herbal medicine for the treatment of cerebral
ischemia has a long history in China. Traditional Chinese
medicines, such as Panax notoginseng9, Scutellaria baicalensis
Georgi10, Puerariae11, and Nardostachys12, have been used to
treat cerebral ischemia for thousands of years in China. Tribulus
terrestris is an annual plant found around the world. It has been
used for the treatment of eye problems, edema, abdominal
distention, kidney troubles, and sexual dysfunction. The gross
saponins of T. terrestris (GSTT) are a group of the effective
ingredients extracted from the whole plant of caltrop. It is a
mixture of over 10 kinds of saponins, mainly steroid saponins.
These saponins have been commercially available as active
compounds in traditional Chinese medicine formulations13,
such as ‘‘Xin-nao-shutong’’, which has been used for the
treatment of cardiovascular disease14.
Our previous research has shown that GSTT (at 30 mg/kg)
can protect against cerebral ischemia injury in rats. However,
the underlying protection mechanisms of GSTT, including the
possible involvement of NF-kB, have not been fully explored.
The primary objective of this study was to investigate whether
GSTT acted through the NF-kB pathway in protecting against
cerebral ischemia injury.2. Materials and methods
2.1. Materials
GSTT (purity496%) was purchased from Aodong Taonan
Pharmaceuticals Co. (Jilin, China). DAB kit was provided byBeijing Zhongshan Golden Bridge Biotechnology Co. (Beijing,
China). NF-kB p65 antibody and secondary antibody were
purchased from Santa Cruz. TNF-a kit and IL-1b ELISA kit
were purchased from R&D Systems. All other chemicals used
were of biochemical grade.
2.2. Animals
The experiments were performed on adult male Wistar rats
(n¼50) weighing 220–260 g, clean grade, and purchased from
the Laboratory Animal Center of Bethune Medical College of
Jilin University. Rats were housed under 12 h light–dark
cycles, with room temperature of 2371 1C and relative humid-
ity of 55–65%. The animal handling procedures in the experi-
ment process complied with the China National Institutes of
Healthy Guidelines for the Care and Use of Laboratory
Animals.
2.3. Experimental protocol
Animals were divided into ﬁve groups, each with ten rats. The
ﬁrst group served as sham, and saline was given intraperito-
neally (sham group); the second group was subjected to
MCAO for 24 h (MCAO group); the third group was
pretreated for 7 days with GSTT (30 mg/kg, i.p., once daily)
followed by MCAO for 24 h (MCAOþGSTT group); the
fourth group was pretreated with the NF-kB inhibitor pyrro-
lidine dithiocarbamate (PDTC, 120 mg/kg, i.p.) at 30 min
prior to the onset of the 24-h MCAO (MCAOþ PDTC
group); and the last group was pretreated for 7 days with
GSTT (30 mg/kg, i.p., once daily), followed by treatments
with PDTC and MCAO, as for the 4th group (MCAOþ
GSTTþPDTC group). After the completion of the occlusion
period, the animals were assessed for neuro-behavioral activity
and then sacriﬁced for tissue collection and analysis.
Before the operation, all animals were deeply anesthetized
with chloral hydrate (400 mg/kg, i.p.). MACO was produced
on the right side using an intraluminal ﬁlament model12. The
procedure was done by introducing a nylon ﬁlament with a
rounded tip, via the external cerebral artery (ECA) stump, into
the proximal internal carotid artery (ICA), followed by
arterial ligature. The occlusion was allowed to last for 24 h.
Successful establishment of the MACO model was conﬁrmed
by the induction of Horner’s syndrome, as indicated by
circling motion toward the right and ﬂexible right forelimb.
In sham-operated animals, the ﬁlament was threaded into the
ECA stump, but the artery was not ligated.
2.4. Sample collection and management
After producing MCAO, the rat brains were removed and
then either immediately frozen for later preparation of tissue
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ﬁxed tissues were embedded in parafﬁn and 2–5-mm thick
sections were prepared for HE staining. Serum was stored by
freezing for later detection of the TNF-a and IL-1b levels.
2.5. Measurement of experimental cerebral infarction and
brain water (cerebral edema) and neurological examination
After 24 h of occlusion, rats were sacriﬁced. Rat brains were
quickly removed and immediately sectioned. Tissue was
completely covered in 1% 2,3,5-triphenyl-2H-tetrazolium
chloride (TTC) solution at 37 1C for approximately 15 min.
TTC staining resulted in viable tissue staining a ‘‘brick-red,’’
as the tetrazolium salts reacted with the dehydrogenases in the
cells, and the infarcted tissue staining a pale white, since they
lacked the enzymes with which the TTC would react. The
infarction area was computed using the BI2000 software
system. The extent of brain infarction was calculated accord-
ing to the following equation:
Brain infarction ð%Þ ¼ ðwhite infarct area=slice areaÞ  100%
Brain tissues were immediately weighed to obtain the wetweight and then dried in an oven at 100 1C for 24 h to obtain
the dry weight. The water content was determined as (wet
weightdry weight)/dry weight.
Neurological examination was performed on each rat at
24 h after MCAO surgery to assess the neuro-behavioral
abnormality score. The test was conducted essentially accord-
ing to the method of Bederson et al.15, with minor modiﬁca-
tion. The scoring was done by suspending the rats 20 cm
above the ground. Intact animals extended both forelimbs
toward the ﬂoor. These animals were assigned a score of 0.
Abnormal postures included ﬂexing the contralateral limb
toward the body and/or rotating the contralateral shoulder
and limb medially. Rats displaying abnormal postures were
further analyzed by being placed on a sheet of soft, plastic-
backed paper that could be gripped by its claws. Lateral
pressure was applied from behind the shoulders, so that the
forelimbs slid gently to the left and then to the right. Rats that
resisted sliding in both directions were graded as 1, while more
severely affected animals exhibiting a decreased resistance to
the lateral push were scored as 2, and those that circled toward
the paretic side consistently were graded as 3.
2.6. HE staining
After deparafﬁnization and hydration, the sections were
stained in hematoxylin solution and then washed in running
tap water, followed by differentiation in 1% acid alcohol for
30 s. The sections were washed with running tap water again,
and then placed in 0.2% ammonia water, followed by staining
in eosin solution for 30 s–1 min. At last, sections were
dehydrated through alcohol and cleared in xylene. Sections
were examined under an optical microscope.
2.7. Western blot analysis of NF-kB p65 protein
Western blot analysis was performed with equal amounts of
total protein from tissue homogenate (30 mg) or the nuclear
fraction (20 mg), prepared according to Dignam et al.16 The
proteins were separated with 10% SDS-PAGE gels and
transferred to PVDF membranes (Millipore, USA).Membranes were blocked with 5% nonfat milk for 2 h at
room temperature, washed (with PBS), and then incubated
overnight at 4 1C with the primary antibody (rabbit polyclonal
anti-rat NF-kB p65, 1:1000 dilution). Then the membranes
were washed three times and incubated with secondary anti-
body (goat anti-rabbit, 1:1000 dilution) for 2 h at room
temperature. Immunoreactive bands were visualized using
DAB chromogen, quantiﬁed by image analyzer (Tanon-2008,
China). NF-kB protein levels were normalized to that of
b-actin.
2.8. ELISA for TNF-a and IL-1b
TNF-a and IL-1b were measured by ELISA kit according to
the manufacturer’s instructions, with a detection limit of
1.0 ng/mL.
2.9. Statistical analysis
Values are presented as mean7SD. The SPSS 11.0 software
was used for data analysis. T-test was performed for the
differences between two groups. Po0.05 was regarded as
statistically signiﬁcant.
3. Results
3.1. Effects of GSTT on MCAO-induced infarction, cerebral
edema, and neuro-behavioral abnormality
Twenty-four hours of MCAO injury resulted in a prominent
infarction. GSTT (30 mg/kg) signiﬁcantly reduced the ratio of
the percent infarct area to the whole cerebral area as indicated
by comparisons between the MCAOþGSTT group and the
MCAO group. The protective effect of GSTT was reduced by
treatment with the NF-kB inhibitor PDTC (Fig. 1A).
Twenty-four hours of MCAO injury resulted in a promi-
nent increase in brain water content as compared to sham-
operated rat brain. In the MCAOþGSTT group, the brain
water content was reduced. A signiﬁcant increase in brain
water content was also noted in the MCAOþGSTTþPDTC
group in comparison to the MCAOþGSTT group (Fig. 1B).
MCAO rats showed prominent neurological deﬁcits. GSTT
(30 mg/kg) signiﬁcantly reduced the severity of neuro-beha-
vioral abnormality, as indicated by comparisons between the
MCAOþGSTT group and the MCAO group. In contrast, the
severity of neuro-behavioral abnormality was greater in the
MCAOþGSTTþPDTC group than in the MCAOþGSTT
group (Fig. 1C).
3.2. Effect of GSTT on MCAO-induced histological changes
As shown in Fig. 2, neurocytes had evenly distributed chromatin,
with no mesenchyma edematous, and had normal appearance in
the sham-operated group. In the MCAO group, there was edema
in the brain tissue and inﬂammatory cell inﬁltration in mesench-
yma; neurocytes became triangular in shape, and there were also
vacuoles. GSTT treatment alleviated edema and inﬂammatory
cell inﬁltration, but PDTC treatment reduced the effects of
GSTT, and caused further aggravation of the cerebral lesion, as
shown by the large numbers of necrotic neurocytes and the large
area of brain edema.
Figure 1 Effect of GSTT on various parameters measured 24 h after middle cerebral artery occlusion in rats (n¼10). Treatment of GSTT
(30 mg/kg) was started as intraperitoneal injections for 7 days, and PDTC (120 mg/kg) was intraperitoneally injected for 30 min, followed by
middle cerebral artery occlusion for 24 h. The ﬁgure represents the % infarct area (A), brain water content, (B) and the water content (g/g of
dry weight) of brain tissue as described in methods and neuro-behavioral abnormality score (C). Neurological score was assessed at 24 h after
middle cerebral artery occlusion. Neuro-behavioral abnormality score on a scale of 0–3. Data are expressed as mean7SD; WWPo0.01 in
comparison with sham group, #Po0.05 in comparison with MCAO group; and Po0.05 in comparison with MCAOþGSTT group.
Figure 2 Effect of GSTT on brain HE staining observed 24 h after middle cerebral artery occlusion in rats. Treatment of GSTT (30 mg/kg)
was started as intraperitoneal injections for 7 days, and PDTC (120 mg/kg) was intraperitoneally injected for 30 min, followed by middle
cerebral artery occlusion for 24 h: (A) sham group, (B) MCAO group, (C) MCAOþGSTT group, (D) MCAOþPDTC group, and (E)
MCAOþGSTTþPDTC group. Magniﬁcation, 400.
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To investigate the mechanism of GSTT action, NF-kB expres-
sion was examined. There was a signiﬁcant decrease in brain NF-kB expression in the MCAO group, compared to the sham
group. Treatment with GSTT increased the expression of NF-
kB, whereas treatment with PDTC reduced the expression of
NF-kB and blocked the protective effect of GSTT (Fig. 3).
Figure 3 Effect of GSTT on Western blot of NF-kB p65 observed 24 h after middle cerebral artery occlusion in rats. Treatment of
GSTT (30 mg/kg) was started as intraperitoneal injections for 7 days, and PDTC (120 mg/kg) was intraperitoneally injected for 30 min,
followed by middle cerebral artery occlusion for 24 h. (A) Total protein and (B) nuclear protein in brain of rats. Top: Representative
immunoblot for NF-kB p65. Bottom: Densitometric quantiﬁcation of immunoblot band intensities in ﬁve groups. Data are shown as
mean7SD; WWPo0.05 in comparison with sham group; #Po0.05 in comparison with MCAO group; Po0.01 in comparison with
MCAO group; and Po0.05 in comparison with MCAOþGSTT group.
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Neutrophilic inﬁltration in cerebral ischemia was mediated by
cytokines, including TNF-a and IL-1b. As shown in Fig. 4,
TNF-a and IL-1b levels in the MCAO group were simulta-
neously elevated, compared to the sham group. The MCAO-
induced increase in TNF-a and IL-1b levels was inhibited by
GSTT. However, treatment with PDTC did not decrease the
inhibitory effect of GSTT, and the MCAOþPDTC group did
not show reduced TNF-a and IL-1b levels in comparison with
the MCAO group.Figure 4 Effects of GSTT on cytokines TNF-a and IL-1b levels in
serum of rats subjected to MCAO. Treatment of GSTT (30 mg/kg)
was started as intraperitoneal injection for 7 days, and PDTC
(120 mg/kg) was intraperitoneally injected for 30 min, followed by
middle cerebral artery occlusion for 24 h. TNF-a and IL-1b levels in
serum were detected by ELISA kit. Each column represents
mean7SD of ten rats.
WW
Po0.05 in comparison with sham group
and #Po0.05 in comparison with MCAO group.4. Discussion
Cerebral ischemic injury is a major fatal disease. There is no
proven efﬁcient treatment for such a condition; the difﬁculty is
primarily because of the involvement of a multitude of events in
the pathogenesis of neuronal injury17. In order to use the
traditional Chinese medicines to treat cerebral ischemia more
reliably and more widely, we have investigated the neuroprotec-
tive action of GSTT. In the present work, we have demonstrated
that GSTT can prevent ischemia-induced brain injury and
inﬂammation. We show that GSTT can reduce MCAO-induced
brain infarction, brain edema, and neurological deﬁcits. At the
same time, GSTT can improve MCAO-induced pathologic
changes in brain tissue and suppress the increases in TNF-a
and IL-1b levels in the serum. Moreover, GSTT can up-regulate
the expression of NF-kB; the latter is apparently important for
the mechanism of protection by GSTT against cerebral ischemia
injury, given the observation that the protective effects of GSTT
were inhibited by the NF-kB inhibitor PDTC.
NF-kB is a key transcription factor for many genes
involved in cerebral ischemic injury and inﬂammatory
responses, including genes encoding TNF-a and IL-1b17.
NF-kB activity can support neuronal survival18. NF-kB is
essential for ischemic preconditioning, after a brief period of
brain ischemia, the presence of NF-kB could protect neurons
against a subsequent, prolonged period of ischemia5.Furthermore, blocking NF-kB activation pharmacologically
with diethyldithiocarbamate could inhibit the protective effect
of NF-kB in ischemic preconditioning. These and other
evidence strongly support the idea that NF-kB plays a
physiological role in maintaining neuronal survival19. Our
Western blot analysis veriﬁed that there was a signiﬁcant
decrease in NF-kB expression in MCAO rats compared to the
sham group. Treatment with GSTT increased the expression
of NF-kB. These results suggest that GSTT’s neuroprotective
role might be associated with NF-kB.
The observed increases in TNF-a and IL-1b levels, and the
simultaneous decrease in NF-kB levels, in the MCAO rats are
consistent with the previous ﬁndings by others. Cerebral
ischemia is known to induce inﬂammatory mediators, includ-
ing TNF-a and IL-1b, at the transcriptional level in both
neurons and glial cells20. However, cerebral ischemia is also
En-ping Jiang et al.26known to initiate a ‘‘rapid and progressive loss of cortical
NF-kB within the ischemic core and nearby penumbra’’8.
As pointed out by Botchkina et al.8, the simultaneous loss of
NF-kB activity and increase in TNF expression can exacerbate
cellular damage in both neuronal and glial cells. Thus, the
suppression of serum TNF-a and IL-1b and the concurrent
enhancement of NF-kB expression both seem to contribute to
the observed protection by GSTT against ischemic injury in
MCAO rats.
It is interesting that the NF-kB inhibitor PDTC could
inhibit the effect of GSTT on NF-kB, but not the effect of
GSTT on TNF-a. Previous studies have shown that the ability
of TNF to cause cytotoxicity is much dependent on the loss of
NF-kB activity21. Therefore, our results seem to suggest that
GSTT reduced TNF-a cytotoxicity in the MCAO rats through
the increased expression of NF-kB.
5. Conclusion
In summary, the present study demonstrated that GSTT has a
signiﬁcant protective effect against cerebral ischemia, and that
the mechanism of protection appears to include both activa-
tion of the NF-kB pathway and inhibition of the production
of inﬂammatory cytokines.
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